# Sant P. Chawla, MD – FDA Inspection, Jun 30, 2026

Source: https://www.keypedia.com/records/fda_inspections/sant-p-chawla-md/3c3a42fe-8e34-4a8b-8a5c-0b64111ab2b9
Source feed: FDA_Inspections

> FDA inspection 1324454 of Sant P. Chawla, MD, June 30, 2026. 2 citations under 21 CFR part 312. Form 483 issued. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1324454
- Company Name: Sant P. Chawla, MD
- Inspection Date: 2026-06-30
- Project Area: Bioresearch Monitoring
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Los Angeles District Office
- Citation Count: 2

## Related Documents

- [FDA Inspection 1167324 - 2022-04-15](https://www.keypedia.com/records/fda_inspections/sant-p-chawla-md/fc9ea0cd-7118-4192-be16-3f8f20ae2c42)
- FDA Inspection 945678 - 2015-10-13
- FDA Inspection 757044 - 2011-12-13
- FDA Inspection 757043 - 2011-11-30
- FDA Inspection 722028 - 2011-04-29

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/bruno-baltazar/95a94f09-6e24-4454-a18d-4cef89e721d9)
- [Issuing Officer](https://www.keypedia.com/people/jose-a-leyva/0c0ffdd3-cd41-4e30-bf61-e96f62a58921)

Company: https://www.keypedia.com/companies/sant-p-chawla-md/12b13bee-4e0f-4d72-a3a7-217e48fb68ef

Office: https://www.keypedia.com/offices/los-angeles-district-office/edcf1dfe-596a-43b8-8df4-07d9cd94763b
